Logo image
Repurposing Estrogen Receptor Antagonists for the Treatment of Infectious Disease
Journal article   Open access   Peer reviewed

Repurposing Estrogen Receptor Antagonists for the Treatment of Infectious Disease

Marhiah C Montoya and Damian J Krysan
mBio, Vol.9(6), p.e02272-18
12/18/2018
DOI: 10.1128/mBio.02272-18
PMCID: PMC6299222
PMID: 30563895
url
https://doi.org/10.1128/mBio.02272-18View
Published (Version of record) Open Access

Abstract

The concept of repurposing previously approved medications to the treatment of new indications by taking advantage of off-target effects has gained traction in recent years, particularly in areas of medicine that do not offer large profits to pharmaceutical firms. As infectious disease discovery research has declined among large pharmaceutical companies, the potential payoff of repurposing has become attractive. From these efforts, the triphenylethylene class of selective estrogen receptor modulators related to tamoxifen has shown activity against a wide range of medically important human pathogens, including bacteria, fungi, parasites, and viruses. Because it has activity against many pathogens affecting people in resource-limited areas of the world, TAM and related drugs may be particularly useful. Here, we review the , , and mechanistic studies of the anti-infective activity of tamoxifen, toremifene, clomiphene, and their analogs. We also discuss the pharmacologic properties of this privileged scaffold and its potential utility in treating infectious diseases.
Stilbenes - therapeutic use Humans Bacteria - drug effects Toremifene - analogs & derivatives Viruses - drug effects Drug Repositioning Estrogen Receptor Antagonists - pharmacology Parasites - drug effects Animals Communicable Diseases - drug therapy Tamoxifen - pharmacology Tamoxifen - analogs & derivatives Female Mice Toremifene - pharmacology

Details

Metrics

Logo image